¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-11-11
±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : 2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ ₩50,000, Àü°øÀÇ, °£È£»ç ¹× ±âŸ ₩20,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 A·ë 10:00~11:00 Past and future of WHO classification of lymphoid neoplasm  °í¿µÇý(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 A·ë 11:00~12:00 Distinction of live immune cells by fluorescent probe  À念ÅÂ(Æ÷Ç×°ø´ë) 
±³À°½Ã°£ 11-11 C·ë 13:00~13:40 Emerging trends and Korean real-world of CAT(cancer-associated thrombosis)  ÀÌÁöÇö(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 11-11 C·ë 13:40~14:20 Thrombosis in ITP(immune thrombocytopenic purpura)  ±è»ó¾Æ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-11 C·ë 14:20~15:00 Alternatives to blood transfusion and prophylactic transfusion  ±è°æÇÏ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-11 B·ë 15:30~16:00 Clinical, pathological, and genomic features of follicular helper T-cell derived lymphomas  À±»óÀº(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-11 B·ë 16:00~16:30 Novel therapeutic agents for T-cell lymphomas  Á¶Çü¿ì(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-11 B·ë 16:30~17:00 The role of allogeneic stem cell transplantation in T-cell lymphomas  Àü¿µ¿ì(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-11 B·ë 17:00~17:30 Current treatment strategies for extranodal NK/T cell lymphoma  Á¶Àçö(¿ï»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇÑÇ÷¾×ÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѳúÁ¹ÁßÇÐȸ ICSU(International Conference Stroke Update) 2022 & 2nd AKJSC(Australian-Korean Joint Stroke Congress) 11/10~12(2ÀÏÂ÷) : 2022-11-11
´ÙÀ½±Û ´ëÇѼºÇü¿Ü°úÇÐȸ PRS KOREA 2022 Day1 : 2022-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
302 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦25Â÷ ¼­¿ï½ÉÆ÷Áö¿ò : 2018-08-19 0 548 2018-08-08
301 ¼­¿ï Á¦4ȸ ´ëÇѽŰæ¿Ü°úº´¿øÇùÀÇȸ Çмú´ëȸ : 2018-08-19 0 1,276 2018-08-08
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 772 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 541 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 1,034 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,209 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 612 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,541 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 638 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,094 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 926 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 566 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,163 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 884 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,258 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷